Valuation: Orion Infusion Limited

Market Cap 6.37B 51.72M 45.22M 41.71M 38.34M 72.65M 4.98B 73.89M 498M 195M 2.43B 194M 190M 8.38B P/E 2024
231x
P/E 2025 182x
Enterprise Value 6.67B 54.17M 47.36M 43.69M 40.16M 76.1M 5.21B 77.4M 522M 205M 2.55B 203M 199M 8.78B EV / Sales 2024
12.2x
EV / Sales 2025 10.1x
Free-Float
59.39%
Yield 2024
0.25%
Yield 2025 0.64%
1 day+6.11%
1 week+7.03%
Current month-1.28%
1 month-2.92%
3 months-7.04%
6 months-12.96%
Current year-9.57%
1 week 290.5
Extreme 290.5
312
1 month 285
Extreme 285
325
Current year 285
Extreme 285
391.8
1 year 285
Extreme 285
587.5
3 years 217.2
Extreme 217.2
726.9
5 years 69.5
Extreme 69.5
1,000
10 years 44
Extreme 44
1,000
Manager TitleAgeSince
Chief Executive Officer 45 2013-12-31
Director of Finance/CFO - 2020-11-07
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 71 2013-12-31
Director/Board Member 71 1983-05-04
Director/Board Member 45 1999-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+6.11%+7.03%-8.58%-11.23% 48.08M
+0.26%-5.19%+49.36%+157.79% 1,028B
-2.17%-5.72%+60.04%+56.12% 611B
+1.59%-2.50%+32.21%+82.76% 432B
+0.98%-1.40%+29.49%+23.12% 323B
-0.34%-3.10%+27.00%+43.66% 277B
+1.63%-11.76%+19.72%+23.20% 257B
+3.39%+2.29%-23.68%-38.33% 217B
+0.95%-2.60%+22.54%+57.32% 192B
+1.44%-2.82%+21.03%+70.36% 161B
Average +1.43%-4.33%+22.91%+46.48% 349.84B
Weighted average by Cap. +0.45%-5.52%+36.02%+77.71%

Financials

2024 2025
Net sales 827M 6.71M 5.87M 5.42M 4.98M 9.43M 646M 9.59M 64.66M 25.37M 316M 25.22M 24.66M 1.09B 665M 5.4M 4.72M 4.35M 4M 7.58M 519M 7.71M 51.96M 20.39M 254M 20.26M 19.82M 875M
Net income 42.33M 344K 300K 277K 255K 483K 33.06M 491K 3.31M 1.3M 16.16M 1.29M 1.26M 55.69M 35.02M 284K 249K 229K 211K 399K 27.35M 406K 2.74M 1.07M 13.37M 1.07M 1.04M 46.08M
Net Debt 290M 2.36M 2.06M 1.9M 1.75M 3.31M 227M 3.37M 22.7M 8.91M 111M 8.85M 8.66M 382M 302M 2.45M 2.14M 1.98M 1.82M 3.44M 236M 3.5M 23.61M 9.26M 115M 9.21M 9.01M 397M
Logo Orion Infusion Limited
Orion Infusion Limited is a Bangladesh-based large volume parenteral (LVP) manufacturing company. The Company is a provider of medicines and healthcare services through approximately 28 brands and 42 presentations of various formulations. It is engaged in the manufacturing and marketing of intravenous (I.V.) fluid, lifesaving intravenous medicine and intravascular saline, which include fluid and nutrient, fluid and electrolyte, fat emulsion for I.V. use, fluid, nutrient and electrolyte, plasma substitute, antiulcerant, osmotic diuretic and amino acid solutions. The Company has the manufacturing facilities to produce I.V. Rehydration Solutions, Electrolyte Solutions, and Solution for Acidosis, Ranitidine I.V. infusion, Anti-Microbial products, namely, Ciprofloxacin I.V., Metronidazole I.V., and others. Its production plant is situated in Maikuli, P.S. Rupganj, and District- Naraynganj, Bangladesh.
Employees
563
Date Price Change Volume
26-07-14 BDT 309.00 +6.11% 544,308
26-07-14 BDT 291.20 +0.10% 120,581
26-07-13 BDT 290.90 -1.56% 155,067
26-07-12 BDT 295.50 -0.71% 170,531
26-07-09 BDT 297.60 +2.55% 211,915
  1. Stock Market
  2. Stocks
  3. ORIONINFU Stock